The Principles of Clinical Cytogenetics - Extra Materials - Springer

Fragile X 511
93. Bennetto, L. and Pennington, B.F. (2002) Neuropsychology. In Fragile X Syndrome: Diagnosis, Treatment, and
Research, 3rd ed. (Hagerman, R.J. and Hagerman, P.J., eds.), The Johns Hopkins University Press, Baltimore, MD,
pp. 206–248.
94. de Vries, B.B.A., Jansen, C.C.A.M., Duits, A.A., et al. (1996) Variable FMR1 gene methylation of large expansions
leads to variable phenotype in three males from one fragile X family. J. Med. Genet. 33, 1007–1010.
95. Kaufmann, W.E., Abrams, M.T., Chen, W., and Reiss, A.L. (1999) Genotype, molecular phenotype, and cognitive
phenotype: correlations in fragile X syndrome. Am. J. Med. Genet. 83, 286–295.
96. Tassone, F., Hagerman, R.J., Iklé, D.N., et al. (1999) FMRP expression as a potential prognostic indicator in fragile X
syndrome. Am. J. Med. Genet. 84, 250–261.
97. Hagerman, R.J. and Hagerman, P.J. (eds.) (2002) Fragile X Syndrome: Diagnosis, Treatment, and Research, 3rd ed.,
The Johns Hopkins University Press, Baltimore, MD.
98. Hagerman, R.J., Staley, L.W., O’Conner, R., et al. (1996) Learning-disabled males with a fragile X CGG expansion in
the upper premutation size range. Pediatrics 97, 122–126.
99. Hagerman, R.J., Leehey, M., Heinrichs, W., et al. (2001) Intention tremor, parkinsonism, and generalized brain atrophy
in male carriers of fragile X. Neurology 57, 127–130.
100. Rousseau, F., Heitz, D., Tarleton, J., et al. (1994) A multicenter study on genotype-phenotype correlations in the fragile
X syndrome, using direct diagnosis with probe StB12.3: the first 2,253 cases. Am. J. Hum. Genet. 55, 225–237.
101. Loesch, D.Z., Hay, D.A., and Mulley, J. (1994) Transmitting males and carrier females in fragile X—revisited. Am. J.
Med. Genet. 51, 392–399.
102. Myers, G.F., Mazzocco, M.M.M., Maddalena, A., and Reiss, A.L. (2001) No widespread psychological effect of the
fragile X premutation in childhood: evidence from a preliminary controlled study. J. Dev. Behav. Pediatr. 22, 353–359.
103. Tassone, F., Hagerman, R.J., Taylor, A.K., Gane, L.W., Godfrey, T.E., and Hagerman, P.J. (2000) Elevated levels of
FMR1 mRNA in carrier males: a new mechanism of involvement in the fragile-X syndrome. Am. J. Hum. Genet. 66, 6–15.
104. Tassone, F., Hagerman, R.J., Chamberlain, W.D., and Hagerman, P.J. (2000) Transcription of the FMR1 gene in individuals
with fragile X syndrome. Am. J. Med. Genet. (Semin. Med. Genet.) 97, 195–203.
105. Kenneson, A., Zhang, F., Hagedorn, C.H., and Warren, S.T. (2001) Reduced FMRP and increased FMR1 transcription
is proportionally associated with CGG repeat number in intermediate-length and premutation carriers. Hum. Mol. Genet.
10, 1449–1454.
106. Mazzocco, M.M.M. (2000) Advances in research on the fragile X syndrome. Ment. Retard. Dev. Disabil. Res. Rev. 6,
96–106.
107. Warren, S.T. and Sherman, S.L. (2001) The fragile X syndrome. In The Metabolic and Molecular Basis of Inherited
Disease, 8th ed. (Scriver, C.R., Beaudet, A.L., Sly, W.S., and Valle, D., eds.), McGraw-Hill, New York, pp. 1257–1289.
108. Block, S.S., Brusca-Vega, R., Pizzi, W.J., Berry-Kravis, E., Maino, D.M., and Treitman, T.M. (2000) Cognitive and
visual processing skills and their relationship to mutation size in full and premutation female fragile X carriers. Optom.
Vis. Sci. 77, 592–599.
109. Johnston, C., Eliez, S., Dyer-Friedman, J., et al. (2001) Neurobehavioral phenotype in carriers of the fragile X
premutation. Am. J. Med. Genet. 103, 314–319.
110. Cronister, A., Schreiner, R., Wittenberger, M., Amiri, K., Harris, K., and Hagerman, R.J. (1991) Heterozygous fragile
X female: historical, physical, cognitive, and cytogenetic features. Am. J. Med. Genet. 38, 269–274.
111. Schwartz, C.E., Dean, J., Howard-Peebles, P.N., et al. (1994) Obstetrical and gynecological complications in fragile X
carriers: a multicenter study. Am. J. Med. Genet. 51, 400–402.
112. Allingham-Hawkins, D.J., Babul-Hirji, R., Chitayat, D., et al. (1999) Fragile X premutation is a significant risk factor
for premature ovarian failure: the international collaborative POF in fragile X study—preliminary data. Am. J. Med.
Genet. 83, 322–325.
113. Sherman, S.L. (2000) Premature ovarian failure in the fragile X syndrome. Am. J. Med. Genet. (Semin. Med. Genet.) 97,
189–194.
114. Black, S.H., Levinson, G., Harton, G.L., et al. (1995) Preimplantation genetic testing (PGT) for fragile X (fraX). Am. J.
Hum. Genet. 57, A31 (abstract).
115. Sermon, K., Seneca, S., Vanderfaeillie, A., et al. (1999) Preimplantation diagnosis for fragile X syndrome based on the
detection of the non-expanded paternal and maternal CGG. Prenat. Diagn. 19, 1223–1230.
116. Platteau, P., Sermon, K., Seneca, S., Van Steirteghem, A., Devroey, P., and Liebaers, I. (2002) Preimplantation genetic
diagnosis for fragile Xa syndrome: difficult but not impossible. Hum. Reprod. 17, 2807–2812.
117. Hundscheid, R.D.L., Braat, D.D.M., Kiemeney, L.A.L.M., Smits, A.P.T., and Thomas, C.M.G. (2001) Increased serum
FSH in female fragile X premutation carriers with either regular menstrual cycles or on oral contraceptives. Hum.
Reprod. 16, 457–462.
118. Howard-Peebles, P.N. (1996) Letter to the editor. Successful pregnancy in a fragile X carrier by donor egg. Am. J. Med.
Genet. 64, 377.
119. Youings, S.A., Murray, A., Dennis, N., et al. (2000) FRAXA and FRAXE: the results of a five year survey. J. Med.
Genet. 37, 415–421.